Amifloxacin

Drug Profile

Amifloxacin

Alternative Names: WIN 49375; WIN 49375-3

Latest Information Update: 11 Aug 2009

Price : $50

At a glance

  • Originator Sanofi Winthrop
  • Developer Sanofi Winthrop; Yamanouchi
  • Class Antibacterials; Fluoroquinolones; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Gram-negative infections; Septic shock; Urinary tract infections

Most Recent Events

  • 30 Nov 1995 Discontinued-I for Septic shock in Japan (IV)
  • 30 Nov 1995 Discontinued-I for Urinary tract infections in Japan (PO)
  • 30 Nov 1995 Discontinued-II for Septic shock in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top